Potential Drug Interactions Of Oral Antidiabetic In Prescriptions Of Type 2  Diabetes Mellitus Patients At Kumpulan Pane Hospital

Rumanda Nurhasanah; Khairunnisa; Urip Harahap

doi:10.46729/ijstm.v2i4.278

Rumanda Nurhasanah Postgraduate Programs Faculty of Pharmacy, Universitas Sumatera Utara, Medan, 20155, Indonesia
Khairunnisa Faculty of Pharmacy, Universitas Sumatera Utara, Medan, 20155, Indonesia
Urip Harahap Departement of Pharmacology, Faculty of Pharmacy, Universitas Sumatera, Medan, 20155, Indonesia

DOI: https://doi.org/10.46729/ijstm.v2i4.278

Keywords: Potential Drug Interactions, Oral Antidiabetics, Prescription

Abstract

Diabetes Mellitus is a disease that can cause complications of other diseases so that the treatment to be given becomes more and this has the potential for interactions between drugs that can affect the physiological condition of the patient. The aim of this study is to analyze the potential of oral antidiabetic interactions on prescription at Kumpulan Pane Hospital. Analysis of potential oral antidiabetic interactions on a prescription using quantitative research methods is retrospective descriptive. Prescriptions used are inpatient and outpatient prescriptions for the period January-December 2020 that get oral antidiabetics. Analyze data using Medscape and Drugs.com sites. Based on analysis of 9.818 prescription sheets of diabetes mellitus patients, there were found 6.454 (65.73%) prescription of potential oral antidiabetic interactions. Potential interaction of an oral antidiabetic group of 10.759 (91.45%) drug, the pattern of interaction mechanisms most often is pharmacodynamic 73.25%. The most common type of oral antidiabetic drugs that have potential interactions is the biguanide group (metformin) 36.76%. The severity of the most frequent interactions was 92.21%. The conclusion of the potential interactions oral antidiabetic are still found in prescriptions that is 65.73% at Kumpulan Pane Hospital.

Keyword: Potential Drug Interactions, Oral Antidiabetics, Prescription

Downloads

Download data is not yet available.

References

[1] Fatimah, R.N. 2015. Diabetes Mellitus Type 2. Journal of Majority. University of Lampung. 4(5): 95-100.
[2] Utami, M.G. 2013. Analisis Potensi Interaksi Obat Antidiabetik Oral Pada Pasien Di Instalasi Rawat Jalan ASKES Rumah Sakit Dokter Soedarso Pontianak Periode Januari-Maret 2013. Pontianak: Universitas Tanjungpura.
[3] Nurlaelah, I., Mukaddas, A., dan Faustine, I. 2015. Kajian Interaksi Obat Pada Pengobatan Diabetes Melitus Dengan Hipertensi Di Instalasi Rawat Jalan RSUD UNDATA Periode Maret-Juni 2014. Universitas Tadulako: Fakultas MIPA. Jurusan Farmasi. 1(1): 35-41.
[4] Rochjana, A. U. H., Jufri, M., Andrajati, R., Sartika, R. A. D. 2019. Masalah Farmasetika dan Interaksi Obat pada Resep Racikan Pasien Pediatri: Studi Retrospektif pada Salah Satu Rumah Sakit di Kabupaten Bogor. Depok: Universitas Indonesia. Program Studi Magister Farmasi. 8(1): 42-48.
[5] Murtaza, G., Ghani Khan, M. Y., Azhar, S.,Ali Khan, S., M. Khan, T. 2015. Assessment of Potential Drug-Drug Interactions and its Associated Factors in The Hospitalized Cardiac Patients. Saudi Pharmaceutical Journal.
[6] American Diabetes Association. 2019. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes.
[7] Menteri Kesehatan RI. 2016. Peraturan Menteri Kesehatan Republik Indonesia No. 72 Tahun 2016 Tentang Standar Pelayanan Kefarmasian di Rumah Sakit. Jakarta: Kementerian Kesehatan Republik Indonesia.
[8] Handayani, K. 2015. Analysis of Potential Interaction of Diabetes Mellitus Drugs On Prescription Of Outpatient Drugs At DR. Mintohardjo Hospital. UIN Syarif Hidayatullah Jakarta.
[9] Drugs.com. Accessed May 2021.. http://www.drugs.com/drug_interaction.php .
[10] Medscape.com. Diakses May 2021. http://www.medscape.com.interaction checker.